SMTL ID : 5k13.1

Crystal structure of the RAR alpha ligand-binding domain in complex with an antagonist

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.85 Å

Oligo State

monomer

Ligands

1 x 6Q7: 4-{5-(3-tert-butylphenyl)-1-[4-(methylsulfonyl)phenyl]-1H-pyrazol-3-yl}benzoic acid(Non-covalent)

6Q7.1: 19 residues within 4Å: Chain A: W.45, F.48, L.51, S.52, C.55, L.86, L.89, I.90, I.93, R.96, F.106, S.107, G.121, F.122, G.211, R.214, V.215, M.226, P.227 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:W.45, A:F.48, A:F.48, A:L.86, A:L.89, A:I.90, A:I.93, A:F.122, A:F.122, A:F.122, A:V.215 Hydrogen bonds: A:S.107 Water bridges: A:R.96 Salt bridges: A:R.96 pi-Stacking: A:F.106

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hughes, N.E. et al., Identification of potent and selective retinoic acid receptor gamma (RAR gamma ) antagonists for the treatment of osteoarthritis pain using structure based drug design. Bioorg.Med.Chem.Lett. (2016)

Release Date

2016-06-22

Peptides

Retinoic acid receptor alpha: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Retinoic acid receptor alpha